ATS Medical hits on delays in 3F acquisition, restates earnings
This article was originally published in Clinica
Executive Summary
Developer of cardiac surgery devices ATS Medical has extended its agreement to acquire 3F Therapeutics, following a delay in the registration of the transaction with the US Securities and Exchange Commission (SEC).